ProPublica

Journalism in the Public Interest

Cancel

Francisco Hernandez

Government Actions

2009
Warning from FDA
FDA: Failed to ensure investigation was conducted in accordance with plan, failed to maintain adequate case histories, failed to report problems to IRB.

See documents

See the complete list of government actions against doctors.

Story: Drug Firms Say They'll Take Closer Look at Doctors They Pay

ProPublica identified 292 doctors who had been sanctioned or warned by regulators who also were paid by pharmaceutical companies.

To create this list we used our Dollars for Docs database, a compilation of the 17,700 speakers and consultants for eight major drug companies. We matched those names against lists of sanctioned physicians in the 30 most populous states and warning letters issued by the U.S. Food and Drug Administration.

We reviewed each case, summarized the findings and uploaded the underlying documents so they can be searched on our website.

The payments are listed as we compiled them in November 2010 and so the displayed total may not be up-to-date. Do a search to find the recipient's latest payments.

  • Because the review covered only 30 states, there may be other practitioners in the Dollars for Docs database that also have a record of regulatory sanctions.
  • Payee names were primarily checked against medical and osteopathic boards. However, some practitioners are nurses, pharmacists or other health providers.
  • Cases that involved minor, non-medical infractions, such as failing to update addresses or to take continuing medical education courses, were not included in our list of 290 sanctioned practitioners.
  • Pending accusations were not included unless the practitioner had been previously sanctioned.
  • The quality of information and the severity of the discipline imposed vary greatly by state. The same infraction may lead to harsh restrictions in one state and a mild rebuke in another.
  • Some states remove older disciplinary actions from their websites. These actions generally are not included.
  • The list does not necessarily note if a practitioner’s sanction or practice restrictions were modified or terminated. Documents detailing such modifications are posted where available.
  • The list may not include sanctions imposed after ProPublica completed its state searches. To check current status, consult the state medical board.
  • We relied on a regulator’s summary of its actions when available. As a result, our list of sanctions may not include all penalties, such as required monitoring or classes.
If you are a listed practitioner and believe you do not belong in this database, please contact us at ornstein.weber@propublica.org.

Payment Records

Total Received
$19,400
Payments Received At
Miami, Fla.

The following is the list of records we used to add up the total payments for Francisco Hernandez

GlaxoSmithKline
2009 Q2-Q4
$10,400
Payee
Endo Care Incorporated
Listed Name
Hernandez-De Leon, Francisco
City
MIAMI
State
FL
Speaker fee 10400
Eli Lilly
2009 Q1-Q4
$4,000
Payee
ENDOCARE INC.
Listed Name
HERNANDEZ, FRANCISCO O.
City
MIAMI
State
FL
Number of activities 2
Advising/Consulting and International Education Programs 4000.00
Total 4000.00
GlaxoSmithKline
2010 Q1-Q2
$3,000
GlaxoSmithKline has since updated its 2010 report, so this healthcare provider's amount may have changed.
Payee
Endo Care Incorporated
Listed Name
Hernandez-De Leon, Francisco
City
MIAMI
State
FL
Speaker fee 3000
Eli Lilly
2010 Q1-Q2
$2,000
Eli Lilly has since updated its 2010 report, so this healthcare provider's amount may have changed.
Payee
ENDOCARE INC.
Listed Name
HERNANDEZ, FRANCISCO O
City
MIAMI
State
FL
Advising/Consulting and International Education Programs 2000.00
Total 2000.00